BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4076751)

  • 1. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
    Paulick R; Caffier H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R; Caffier H
    Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM; Staab HJ; Anderer FA
    Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
    Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
    Quentmeier A; Schlag P; Herfarth C
    Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
    Ahlemann LM; Staab HJ; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer.
    Lang BA; Kocent A; Nekulová M; Hlávková J
    Neoplasma; 1984; 31(1):79-87. PubMed ID: 6700798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
    Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T
    Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of serum CEA determination in the diagnosis of colo-rectal cancer].
    Jiang R
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):348-51. PubMed ID: 2620629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.